GMT Capital’s AtriCure ATRC Stock Holding History

GMT Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-73,193	Closed	-$1.43M	–	124
2016 Q4	$1.43M	Sell	73,193 -500	-0.7%	-$9.06K	0.03%	114
2016 Q3	$1.17M	Buy	+73,693	New	+$1.13M	0.02%	115

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

GMT Capital's ATRC Position: Q1 2017 in Review

GMT Capital sold out of AtriCure (ATRC) in Q1 2017, closing a stake of 73,193 shares — an estimated $1.43M sold.

GMT Capital first reported a position in ATRC in Q3 2016 and held it in 2 quarters. The position peaked at $1.43M in Q4 2016. 99 funds tracked by Wall St. Rank hold ATRC as of Q1 2017.

GMT Capital reported no remaining AtriCure position as of Q1 2017 after selling out during the quarter.
GMT Capital sold 73,193 AtriCure shares in Q1 2017, an estimated $1.43M.
GMT Capital first reported a position in AtriCure in Q3 2016 and held it in 2 quarters.
GMT Capital's AtriCure position peaked at $1.43M in Q4 2016.
99 funds tracked by Wall St. Rank held AtriCure as of Q1 2017.

Based on GMT Capital's 13F filing for Q1 2017, filed 12 May 2017.